Indica News
  • Home
  • News
    • Production
    • Pharma
    • Dispensaries
    • Investors
    • Sales and Operations
    • Consumer
    • Events and Networking
    • Politics and Law
  • Directory
    • Dashboard
  • Login or Register
  • Account
Select Page
Growing Number of States Allow Reimbursement of Medical Cannabis Costs by Workers’ Compensation Insurance

Growing Number of States Allow Reimbursement of Medical Cannabis Costs by Workers’ Compensation Insurance

by InfluencER | Sep 24, 2021 | Pharma

A limited but growing number of states permit eligible patients to be reimbursed for their medical cannabis-related costs through their workers’ compensation insurance (WCI) plans, according to a just-published analysis of state policies conducted by the National...
Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”

Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”

by InfluencER | Sep 24, 2021 | Pharma

For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities. Scientists have identified at least 113 different chemicals in the plant — with tetrahydrocannabinol (THC) and cannabidiol (CBD) —...
Delta-8 marijuana products can be dangerous, health officials warn

Delta-8 marijuana products can be dangerous, health officials warn

by InfluencER | Sep 15, 2021 | Pharma, Politics and Law

U.S. health officials are warning about the potential dangers of “delta-8 THC,” a compound derived from marijuana, after seeing an increase in hospitalizations tied to the substance. On Tuesday (Sept. 14), both the Centers for Disease Control and...
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

by InfluencER | Sep 9, 2021 | Pharma

Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex®, Dronabinol, and Sativex® – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, released today by global cannabis...
JAMA Study Finds “Little Evidence” of Link Between Cannabis Legalization and Youth Use

JAMA Study Finds “Little Evidence” of Link Between Cannabis Legalization and Youth Use

by InfluencER | Sep 8, 2021 | Pharma

A new, updated study published Monday in the JAMA Network Open found “little evidence” that adult and medical use cannabis legalization “encourage youth marijuana use.” The study, conducted by researchers from the Department of Agricultural Economics at Montana State...
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

by InfluencER | Sep 3, 2021 | Pharma

Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol, and Sativex – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, from global cannabis industry...
« Older Entries
Next Entries »

Recent Posts

  • US Virgin Islands Governor Plans Marijuana Legalization Special Session And Puts Expected Revenue In Budget
  • North Carolina Senate Approves Medical Marijuana Legalization Bill
  • New York Senate Approves Bill To Mandate Medical Marijuana Health Insurance Coverage
  • Louisiana Widening Access to Medical Marijuana Law
  • Indiana lawmakers to discuss cannabis this summer

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020

Categories

  • Consumer
  • Dispensaries
  • Events and Networking
  • General
  • Investors
  • Pharma
  • Politics and Law
  • Production
  • Sales and Operations
  • Facebook
  • X
  • Instagram
  • RSS
© Indica News | All Rights Reserved | info@indica.news | 1.833.450.9333